Skip to content

News

  1. SpinaFX Medical to Exhibit at Society of Interventional Radiology Annual Scientific Meeting

    Company’s medical advisor will present the SIR 2022 Abstract of the Year TORONTO, ONTARIO, June 10, 2022—Minimally invasive image-guided therapy company, SpinaFX Medical Inc. (SpinaFX), today announced it will exhibit at the Society of Interventional Radiology (SIR) 2022 Annual Scientific Meeting in Boston, MA, June 11-16, at booth 414. Dr. Alexis Kelekis, medical advisor to…

    Read More »
  2. SpinaFX Hits Key Milestones Since Closing its $6.88M Series A Round

    TORONTO, ONTARIO, May 26, 2022— Minimally invasive image-guided therapy start-up, SpinaFX Medical Inc. (SpinaFX), today announced significant milestones hit since closing its $6.88M CDN Series A round in November 2021. SpinaFX has leveraged investment proceeds for patent estate expansion, product enhancements, quality management system implementation, regulatory approval pursuits and commercialization of Triojection®. 1 SpinaFX acquired…

    Read More »
  3. SpinaFX Medical Announces Dr. Kieran Murphy as Chief Medical Officer

    TORONTO, ONTARIO, April 5, 2022 Minimally invasive image-guided therapy start-up, SpinaFX Medical Inc. (SpinaFX), is pleased to announce the appointment of Dr. Kieran Murphy as Chief Medical Officer and member of the Board of Directors of SpinaFX Medical. “Dr. Murphy has been a pioneer in the field of intradiscal ozone for the treatment of herniated…

    Read More »
  4. SpinaFX and StarFish Medical Enter into a Strategic Commercialization Contract Manufacturing Agreement

    October 25, 2021 25 October 2021, Toronto, Canada: Minimally invasive image-guided therapy start-up, SpinaFX medical Inc. (SpinaFX) is pleased to announce the signing of a commercialization contract manufacturing agreement with StarFish Product Engineering Inc. (“StarFish Medical”), Canada’s largest medical device design, development, and manufacturing services organization. “SpinaFX is very pleased to welcome StarFish to the SpinaFX…

    Read More »
  5. SpinaFX Medical announces John Soloninka as Chief Operating Officer 

    October 15, 2021, Toronto, Canada: Minimally invasive image-guided therapy start-up, SpinaFX Medical Inc. (SpinaFX), is pleased to announce the appointment of John Soloninka as Chief Operating Officer. John is a healthtech entrepreneur and ex IBM and Price Waterhouse healthcare system strategist bringing extensive industry, commercialization, regulatory and financing expertise to SpinaFX’s growing team. John previously served…

    Read More »
  6. Mass Device – SpinaFX Medical names chief operating officer

    October 15, 2021 SpinaFX Medical names chief operating officer https://www.massdevice.com/spinafx-medical-names-chief-operating-officer

    Read More »
  7. Fierce Biotech – SpinaFX taps Medtronic, Zimmer Biomet alum as CEO of image-guided pain treatment startup

    October 1, 2021, Toronto, Canada: SpinaFX taps Medtronic, Zimmer Biomet alum as CEO of image-guided pain treatment startup (Link below) https://www.fiercebiotech.com/medtech/spinafx-taps-medtronic-zimmer-biomet-alum-as-ceo-image-guided-pain-treatment-startup

    Read More »
  8. SpinaFX Medical Announces Jeff Cambra as CEO

    September 30, 2021, Toronto, Canada: Minimally invasive image-guided therapy start-up, SpinaFX Medical Inc. (SpinaFX), is pleased to announce the appointment of Jeff Cambra as Chief Executive Officer. Mr. Cambra is a veteran medical device and therapeutics industry executive with an international track record managing product development, commercialization, product portfolios and mergers and acquisitions, with a strong…

    Read More »

Learn more about Triojection®